Cargando…
Drug Prevention and Control of Ventilator-Associated Pneumonia
Ventilator-associated pneumonia (VAP) is one of the most prevalent and serious complications of mechanical ventilation, which is considered a common nosocomial infection in critically ill patients. There are some great options for the prevention of VAP: (i) minimize ventilator exposure; (ii) intensi...
Autores principales: | Xie, Xinming, Lyu, Jun, Hussain, Tafseel, Li, Manxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455059/ https://www.ncbi.nlm.nih.gov/pubmed/31001116 http://dx.doi.org/10.3389/fphar.2019.00298 |
Ejemplares similares
-
Activation of PPAR-γ prevents TERT-mediated pulmonary vascular remodeling in MCT-induced pulmonary hypertension
por: Hussain, Tafseel, et al.
Publicado: (2023) -
Prevention and treatment of ventilator-associated pneumonia in COVID-19
por: Deng, Jiayi, et al.
Publicado: (2022) -
Effects of Gastric Acid Secretion Inhibitors for Ventilator-Associated Pneumonia
por: Li, Fang, et al.
Publicado: (2022) -
The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database
por: Yang, Rui, et al.
Publicado: (2022) -
Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov
por: Chen, Lingmin, et al.
Publicado: (2019)